Notice Number: NOT-OD-15-059

Key Dates
Release Date: January 22, 2015 (Rescinded July 23, 2018)

Issued by
National Institutes of Health (NIH)

Purpose

The purpose of this Notice is to remind applicants that the basic requirements for allowable applications have not changed with the updated NIH/AHRQ policy on application submission (see NOT-OD-14-074 and NOT-OD-14-082). Investigators now may submit a New Application, following an unsuccessful application, without concern for scientific overlap with previously reviewed applications.

New Application
A New Application is an application that has not been previously proposed or received funding. Whether it follows an unsuccessful application or not, a New Application is neither a Resubmission Application nor a Renewal Application, and must comply with the rules for a New Application.

The following content is NOT allowed anywhere in a New Application or its associated components (e.g., the appendix, letters of support, other attachments):

• Introduction page(s) to respond to critiques from a previous review
• Mention of previous overall or criterion scores or percentile
• Mention of comments made by previous reviewers
• Responses to a prior review
• Mention of how the application or project has been modified since its last submission
• Marks in the application to indicate where the application has been modified since its last submission
• Progress Report
• Progress Report Publication List

A New Application that does not conform to the rules for a New Application will not be reviewed and will not be considered for funding. This means that:

• A New Application submitted after an unfunded New Application or a Resubmission Application must be formatted as a New Application and not contain elements of a Resubmission Application (see list above).
• A New Application submitted after an unfunded Renewal Application (or Renewal Resubmission Application) must be formatted as a New Application and not contain elements of either a Renewal Application or a Resubmission Application (see list above).
• A New Application submitted to a Funding Opportunity Announcement for investigator-initiated applications, after it was submitted to a Request for Applications (RFA) but not funded, must be formatted as a New Application.
• A New Application submitted to an RFA after it was submitted as an investigator-initiated application but not funded must be formatted as a New Application.
• A New Application submitted with a change of activity code (for example, from R01 to R21) must be formatted as a New application and not contain elements of a Resubmission Application (see list above).

A phase II Small Business Innovation Research/Small Business Technology Transfer Research (SBIR/STTR) application following a funded phase I SBIR/STTR application is a Renewal Application. As for other Renewal Applications, these phase II SBIR/STTR applications are allowed two submissions: a New phase II application and Resubmission phase II application.

Please see our Frequently Asked Questions Resources for additional information:
FAQs on Resubmission of NIH Applications

Inquiries

Please direct all inquiries to:

Division of Receipt and Referral
NIH Center for Scientific Review (CSR)
Email: [email protected]
Telephone: 301-435-0715

Or

NIH Review Policy Officer
Email: [email protected]

Or

Gerald E. (Jerry) Calderone, Ph.D.
Agency for Healthcare Research and Quality
Telephone: 301-427-1548
Email: [email protected]